Navigation Links
Nanomed to Launch Early Access Program for Revel High-Throughput Direct Measurement Platform for Fragment Screening

Fragment-based lead discovery (FBLD) involves biophysical screening of proteins against libraries of low molecular weight compounds. In this early stage, false positives can be problematic due to high levels of solvents and nonspecific hydrophobic binding. At the same time, it is vital that screening techniques are highly sensitive to detect weak interactions. Nanomed, leading producer of graphene biosensors for pharmaceutical and biotherapeutics research, announces the launch of the Early Access Program for Revel, the first high-throughput direct measurement platform for fragments and small molecules using orthogonal Field Effect Biosensing (FEB) technology.

“Until now, FBLD researchers have had to balance throughput, sensitivity and protein consumption using multiple techniques to cross-check results,” says Nanomed CEO, Ross Bundy. “Revel is on par with ligand-observed NMR in sensitivity and throughput, while using much less protein, even less than thermal shift assays. It is an excellent addition to the arsenal of any scientist who wants to drastically reduce the number of false positives and negatives in their primary screen.”

Revel is a 24-channel direct binding system that is fully automated with a 48-hour walkaway run time, designed to be used with the Nimbus HD liquid handler by Hamilton Robotics. Easy-to-use, built-in software acquires and analyzes data in real time, enabling results for 576 interactions in a day, including analysis. The platform measures up to 10 mM concentrations, ensuring accurate detection of low affinity binding interactions. Revel uses orthogonal FEB technology, a breakthrough electrical sensing technique that is unaffected by optical impediments such as solvents and significantly reduces nonspecific binding.

“We are opening the Revel Early Access Program to experienced researchers with active FBLD screening programs for performance studies and valuable product testing feedback,” continues Mr. Bundy. “Working closely with these development partners is the next step in our vision of bringing accurate, quantitative results to drug discovery pipelines without sacrificing cost or time.”

Nanomed will present Revel at Booth 213 at the 2019 SLAS Conference from February 4 through 6 in Washington, D.C.

About Nanomed

Nanomed is a life science company based in San Diego, California. As the world’s leading manufacturer and developer of next-generation graphene biosensors, Nanomed’s mission is to transform the healthcare industry with innovative new products that enable cutting-edge life science research, drug discovery applications, and portable diagnostic and health monitoring platforms.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clearing up inflammation with pro-resolving nanomedicines
2. New nanomedicine resolves inflammation, promotes tissue healing
3. Nanomedicine Market Expected to Grow at a CAGR of 12.57% by 2016 in New Research Report at
4. Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research
5. The Medicines Patent Pool (MPP) Signs a Collaborative Agreement with the University of Liverpool to Develop HIV Nanomedicines
6. Nanomedical Diagnostics Announces Scientific Advisory Board of Top Scientists and Medical Researchers
7. Nanomedical Diagnostics launches a new graphene biosensor with unprecedented functionality for small molecule and protein analysis
8. NanoViricides Anti-Virus Technology Published in Handbook of Clinical Nanomedicine
9. Nanomedical Diagnostics CEO and CTO to Introduce Electronic Label-Free Assay Based on Field Effect Biosensing Technology at IDTechEx Show
10. Nanomedical Diagnostics to Present Field Effect Biosensing for Fragment-Based Drug Discovery at SLAS 2017
11. Nanomedical Diagnostics Announces Partnership with Rogue Valley Microdevices, Delivering World’s First Successful High-Volume Manufacturing for Graphene Biosensors
Post Your Comments:
(Date:1/24/2019)... ... 22, 2019 , ... Dr. Douglas Stramel of Advanced Care Veterinary Services ... System (V-PET™) for nearly three years. A proponent of Regenerative Medicine, Dr. ... and began using V-PET™ 2016. V-PET™ is a gravity filtration-based platelet therapy kit ...
(Date:1/20/2019)... ... 2019 , ... Consumers are directing healthcare in many ways, ... changing as many services now exist for patients to order tests without a ... million in 2018, according to Kalorama Information’s new report, The Direct-To-Consumer Testing ...
(Date:1/15/2019)... ... 2019 , ... With the U.S. Congress designating January as Cervical Health Awareness Month , ... announces tips to help reduce the risk of Cervical Cancer. , Cervical cancer ... the #1 most common STD and an STI that almost half of all ...
(Date:1/10/2019)... ... 08, 2019 , ... VGI Medical was founded in 2007 based on an ... to the market including VerteLoc, CerLoc, SiJoin and VerteLP. The VerteLoc and CerLoc systems ... patented dual geometric design to limit motion of the affected spinal segment. Applying the ...
Breaking Biology Technology:
(Date:1/20/2019)... ... ... Boston-based Laboratory as a Service (LaaS) leader, Mass Innovation Labs, has changed ... expansion and service offerings for biotech and life sciences companies. , “Meeting ... more agile and adaptable than ever before. One that doubles-down on the things that ...
(Date:1/10/2019)... ... 2019 , ... When Dr. James L. Sherley, M.D., Ph.D., founder and director ... chapter to the new book Perinatal Stem Cells: Research and Therapy, he knew immediately ... debilitating secret of stem cell medicine. For more than a half-century, stem cell ...
(Date:1/8/2019)... ... January 07, 2019 , ... Sonion , ... hearing instruments and specialty earphones, and Valencell , the leading innovator in ... in canal with an embedded biometric sensor. The BiometRIC measures key vital signs ...
Breaking Biology News(10 mins):